BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3612192)

  • 1. Familial Leigh's syndrome: association with a defect in oxidative metabolism probably restricted to brain.
    van Erven PM; Gabreëls FJ; Ruitenbeek W; Renier WO; Lamers KJ; Sloof JL
    J Neurol; 1987 May; 234(4):215-9. PubMed ID: 3612192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leigh's syndrome].
    Sunohara N
    Nihon Rinsho; 1990 Jul; 48(7):1568-72. PubMed ID: 2169544
    [No Abstract]   [Full Text] [Related]  

  • 3. Subacute necrotizing encephalomyelopathy (Leigh syndrome) associated with disturbed oxidation of pyruvate, malate and 2-oxoglutarate in muscle and liver.
    Van Erven PM; Gabreëls FJ; Ruitenbeek W; Den Hartog MR; Fischer JC; Renier WO; Trijbels JM; Slooff JL; Janssen AJ
    Acta Neurol Scand; 1985 Jul; 72(1):36-42. PubMed ID: 4050316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbed oxidative metabolism in subacute necrotizing encephalomyelopathy (Leigh syndrome).
    van Erven PM; Ruitenbeek W; Gabreëls FJ; Renier WO; Fischer JC; Janssen AJ
    Neuropediatrics; 1986 Feb; 17(1):28-32. PubMed ID: 3008021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical study in 28 children with lactic acidosis, in relation to Leigh's encephalomyelopathy.
    Miyabayashi S; Ito T; Narisawa K; Iinuma K; Tada K
    Eur J Pediatr; 1985 Mar; 143(4):278-83. PubMed ID: 2985393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome c oxidase deficiency in subacute necrotizing encephalomyelopathy.
    Arts WF; Scholte HR; Loonen MC; Przyrembel H; Fernandes J; Trijbels JM; Luyt-Houwen IE
    J Neurol Sci; 1987 Jan; 77(1):103-15. PubMed ID: 3027266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subacute necrotizing encephalopathy, Leigh's disease. Apropos of a case].
    Delisle MB; Netter JC; Peyrille F; Bouissou H
    Ann Pathol; 1985; 5(4-5):313-7. PubMed ID: 3833250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current developments in the clinical diagnosis and the biochemical analysis of Leigh's syndrome].
    Arts WF
    Tijdschr Kindergeneeskd; 1989 Jun; 57(3):97-101. PubMed ID: 2799800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous pyruvate loading test in Leigh syndrome.
    Van Erven PM; Gabreëls FJ; Wevers RA; Doesburg WH; Ruitenbeek W; Renier WO; Lamers KJ
    J Neurol Sci; 1987 Feb; 77(2-3):217-27. PubMed ID: 3819766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia.
    Martin JJ; Van de Vyver FL; Scholte HR; Roodhooft AM; Ceuterick C; Martin L; Luyt-Houwen IE
    J Neurol Sci; 1988 Apr; 84(2-3):189-200. PubMed ID: 3379446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leigh's subacute necrotizing encephalomyelopathy due to decreased activity of the pyruvate dehydrogenase complex].
    Siemes H; Goebel HH; Sengers RC; Ruitenbeek W; Trijbels JM
    Monatsschr Kinderheilkd; 1987 Dec; 135(12):821-6. PubMed ID: 3125426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems analysis of energy metabolism elucidates the affected respiratory chain complex in Leigh's syndrome.
    Vo TD; Paul Lee WN; Palsson BO
    Mol Genet Metab; 2007 May; 91(1):15-22. PubMed ID: 17336115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial abnormalities in choroid plexus of Leigh disease.
    Ohama E; Ikuta F; Nakamura N
    Brain Dev; 1988; 10(1):30-5. PubMed ID: 3285724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of pyruvate dehydrogenase complex (PDHC) in Leigh's disease fibroblasts: an abnormality in lipoamide dehydrogenase affecting PDHC activation.
    Hinman LM; Sheu KF; Baker AC; Kim YT; Blass JP
    Neurology; 1989 Jan; 39(1):70-5. PubMed ID: 2909916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency.
    Krägeloh-Mann I; Grodd W; Schöning M; Marquard K; Nägele T; Ruitenbeek W
    Dev Med Child Neurol; 1993 Sep; 35(9):769-76. PubMed ID: 7689066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal kinetic behavior of cytochrome oxidase in a case of Leigh disease.
    Glerum M; Robinson BH; Spratt C; Wilson J; Patrick D
    Am J Hum Genet; 1987 Oct; 41(4):584-93. PubMed ID: 2821802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leigh's disease--several nosological entities with an identical histopathological complex?
    Walter GF; Brucher JM; Martin JJ; Ceuterick C; Pilz P; Freund M
    Neuropathol Appl Neurobiol; 1986; 12(1):95-107. PubMed ID: 3703157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal activities of hepatic pyruvate dehydrogenase and pyruvate carboxylase in Leigh's syndrome.
    Tsuchiyama A; Oyanagi K; Sogawa H; Nakao T; Ogawa K; Fujita S
    Tohoku J Exp Med; 1983 Jan; 139(1):67-72. PubMed ID: 6836560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suspected pyruvate carboxylase deficiency in 4 children with Leigh disease].
    Pronicka E; Kulczycka H; Chmielik J; Krajewska G; Szeffer J
    Neurol Neurochir Pol; 1986; 20(2):89-94. PubMed ID: 3095672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial encephalomyopathy. Association with an NADH dehydrogenase deficiency.
    van Erven PM; Gabreëls FJ; Ruitenbeek W; Renier WO; Fischer JC
    Arch Neurol; 1987 Jul; 44(7):775-8. PubMed ID: 3593065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.